GENERAL ATLANTIC, L.P.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Korsana Biosciences, Inc. 13G
KRSA · 23255M303
6.8% 9/18/2026
Event 9/8/2026
dLocal Ltd 13D/A
DLO · G29018101
21.4% 8/19/2026
Event 8/17/2026
Pharvaris N.V. 13G/A
PHVS · N69605108
7.6% 8/14/2026
Event 6/30/2026
Liftoff Mobile, Inc. 13D
LFTO · 53229X101
15.0% 6/12/2026
Event 6/5/2026
Alkami Technology, Inc. 13D/A
ALKT · 01644J108
18.1% 5/15/2026
Event 5/13/2026
Alignment Healthcare, Inc. 13G/A
ALHC · 01625V104
0.1% 5/15/2026
Event 3/31/2026
Seaport Therapeutics, Inc. 13D
SPTX · 81221K108
11.5% 5/11/2026
Event 5/4/2026
Adagene Inc. 13G/A
ADAG · 005329107
0% 2/17/2026
Event 12/31/2025
XP Inc. 13D/A
XP · G98239109
5.4% 12/4/2025
Event 12/2/2025
Chime Financial, Inc. 13G
CHYM · 16935C109
5.6% 11/10/2025
Event 6/13/2025
Royalty Pharma plc 13G/A
RPRX · G7709Q104
3.2% 8/14/2025
Event 6/30/2025
Akero Therapeutics, Inc. 13G/A
AKRO · 00973Y108
8.4% 5/15/2025
Event 3/31/2025
Third Harmonic Bio, Inc. 13D/A
THRD · 88427A107
0% 2/13/2025
Event 2/11/2025
Blend Labs, Inc. 13G/A
BLND · 09352U108
0% 2/10/2025
Event 12/31/2024